Dr. David S. Hanson
Claim this profileMary Bird Perkins Cancer Center
Expert in Lung Cancer
Studies Breast Cancer
38 reported clinical trials
82 drugs studied
About David S. Hanson
Education:
- Obtained an MD from the University of Colorado School of Medicine, 1985.
- Graduated summa cum laude with an undergraduate degree in Biological Science from the University of Denver.
Experience:
- Possesses over 37 years of experience in Hematology & Oncology.
- Board-certified in Medical Oncology and Internal Medicine.
- Completed internship, residency, and fellowship in Hematology and Oncology at the University of Colorado Health Science Center.
- Serves as a Senior Consultant of Hematology and Oncology services at the Mayo Clinic in Jacksonville, Florida, since 1994.
- Currently practicing at Mary Bird Perkins Cancer Center in Baton Rouge, LA.
Area of expertise
1Lung Cancer
Global LeaderStage IV
Stage II
Stage I
2Breast Cancer
Stage IV
Stage III
HER2 positive
Affiliated Hospitals
Clinical Trials David S. Hanson is currently running
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Nivolumab + Ipilimumab + Sargramostim
for Advanced Melanoma
This phase II/III trial studies the side effects of nivolumab and ipilimumab when given together with or without sargramostim and to see how well they work in treating patients with stage III-IV melanoma that cannot be removed by surgery (unresectable) and that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). Immunotherapy with monoclonal antibodies, such as ipilimumab and nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Colony-stimulating factors, such as sargramostim, may increase the production of white blood cells. It is not yet known whether nivolumab and ipilimumab are more effective with or without sargramostim in treating patients with melanoma.
Recruiting1 award Phase 2 & 323 criteria
More about David S. Hanson
Clinical Trial Related6 years of experience running clinical trials · Led 38 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments David S. Hanson has experience with
- Nivolumab
- Cisplatin
- Atezolizumab
- Paclitaxel
- Ipilimumab
- Carboplatin
Breakdown of trials David S. Hanson has run
Lung Cancer
Breast Cancer
Breast cancer
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David S. Hanson specialize in?
David S. Hanson focuses on Lung Cancer and Breast Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage II.
Is David S. Hanson currently recruiting for clinical trials?
Yes, David S. Hanson is currently recruiting for 7 clinical trials in Baton Rouge Louisiana. If you're interested in participating, you should apply.
Are there any treatments that David S. Hanson has studied deeply?
Yes, David S. Hanson has studied treatments such as Nivolumab, Cisplatin, Atezolizumab.
What is the best way to schedule an appointment with David S. Hanson?
Apply for one of the trials that David S. Hanson is conducting.
What is the office address of David S. Hanson?
The office of David S. Hanson is located at: Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana 70809 United States. This is the address for their practice at the Mary Bird Perkins Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.